Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine
Clinical trial NCT05329038 · UNKNOWN
Trial details
- NCT number
- NCT05329038
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2022-06-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.